GLP-1 agonists (Byetta, etc) are a good choice for weight loss in patients WITHOUT diabetes.
This isn’t completely true. GLP-1 agonists do result in short-term weight loss, but safety is a concern.
Alternative weight loss meds are tempting in light of all the cardiovascular and other concerns with antiobesity drugs.
GLP-1 agonists seem to cause weight loss by slowing gastric motility, increasing satiety, and suppressing appetite.